Hypopharynx
| Primary Site | Histology |
|---|---|
| C129, C130-C132, C138-C139 | 8000-8700 |
Notes
8000-8700 C129 Pyriform sinus C130 Postcricoid region C131 Hypopharyngeal aspect of aryepiglottic fold C132 Posterior wall of hypopharynx C138 Overlapping lesion of hypopharynx C139 Hypopharynx, NOS (laryngopharynx) **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 11 *Oropharynx (p16-) and Hypopharynx*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** See the following schemas for the listed histologies * 8710-8714, 8800-8803, 8810-8905, 8912, 8921, 8932-8934, 8940-8990, 9000-9016, 9030-9043, 9045-9110, 9121-9138, 9141-9230, 9240-9580, 9582: *Soft Tissue Head and Neck* * 8720-8790: *Melanoma Head and Neck* * 8804-8806, 8910, 8920, 8930-8931, 8991, 9020, 9044, 9120, 9231, 9581: *Soft Tissue Rare* * 8935-8936: *GIST* * 8992: *Soft Tissue Other* * 9140: *Kaposi Sarcoma* * 9700-9701: *Mycosis Fungoides* **Note 3:** Testing for p16 is not mandatory or needed for hypopharyngeal cancers.Data Items
| Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
|---|---|---|---|---|---|
| Year of Diagnosis | <BLANK> | No |
NAACCR #390
dateOfDiagnosis |
None | |
| Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
| Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | |
| Behavior | <BLANK> | No |
NAACCR #523
behaviorCodeIcdO3 |
None | |
| Tumor Size Clinical | <BLANK> | No |
NAACCR #752
tumorSizeClinical |
None | |
| Tumor Size Pathological | <BLANK> | No |
NAACCR #754
tumorSizePathologic |
None | |
| Tumor Size Summary | 999 | Yes |
NAACCR #756
tumorSizeSummary |
None | |
| Regional Nodes Positive | 99 | No |
NAACCR #820
regionalNodesPositive |
None | |
| Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
| LVI | 9 | No |
NAACCR #1182
lymphVascularInvasion |
None | |
| RX Summ Surgery/Radiation Sequence | <BLANK> | No |
NAACCR #1380
rxSummSurgRadSeq |
None | |
| RX Summ Systemic/Surgery Sequence | <BLANK> | No |
NAACCR #1639
rxSummSystemicSurSeq |
None | |
| EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
| EOD Regional Nodes | 999 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
| EOD Mets | 00 | Yes |
NAACCR #776
eodMets |
None | |
| SS2018 | <BLANK> | No |
NAACCR #764
summaryStage2018 |
None | |
| Grade Clinical | 9 | No |
NAACCR #3843
gradeClinical |
CCCR/Canada COC NPCR SEER |
SSDI |
| Grade Pathological | 9 | No |
NAACCR #3844
gradePathological |
CCCR/Canada COC NPCR SEER |
SSDI |
| Grade Post Therapy Clin (yc) | <BLANK> | No |
NAACCR #1068
gradePostTherapyClin |
COC NPCR SEER |
SSDI |
| Grade Post Therapy Path (yp) | <BLANK> | No |
NAACCR #3845
gradePostTherapy |
CCCR/Canada COC NPCR SEER |
SSDI |
| Extranodal Exten H&N Clin | 8 | No |
NAACCR #3831
extranodalExtensionHeadNeckClin |
COC SEER (RC) |
SSDI |
| Extranodal Exten H&N Path | X.8 | No |
NAACCR #3832
extranodalExtensionHeadNeckPath |
CCCR/Canada COC SEER |
SSDI |
| Lymph Nodes Size of Mets | XX.8 | No |
NAACCR #3883
lnSize |
CCCR/Canada COC SEER |
SSDI |
| SEER_SSF1: SEER Site-Specific Fact 1 | 9 | No |
NAACCR #3700
seerSiteSpecificFact1 |
None |
Initial Context
Outputs
| Name | Default Value | Description | NAACCR Item | Metadata |
|---|---|---|---|---|
| Schema ID | 00112 |
NAACCR #3800
schemaId |
None | |
| Derived Version | {{ctx_alg_version}} | None | None | |
| Derived Summary Stage 2018 | 9 |
NAACCR #762
derivedSummaryStage2018 |
None |